Fungal infections – Page 14

Northwest Iranian dermatophyte isolates: anthropophilic and geophilic

mycolabadmin

Researchers in northwestern Iran studied fungal infections of skin, hair, and nails by identifying different types of dermatophytes from patient samples and soil. They found that a fungus called Trichophyton mentagrophytes was the most common cause, but also discovered a rare fungus called Myriodontium keratinophilum causing nail infections. Using modern DNA testing methods, they identified seven different dermatophyte species and several other soil fungi, providing important information about fungal infections in this region.

Superficial Fungal Infections in the Pediatric Dermatological Population of Northern Poland

mycolabadmin

This study examined fungal skin infections in children and teens in Northern Poland over six years, finding that about 1 in 5 children tested had a fungal infection. Different types of fungal infections were more common at different ages—younger children more often had scalp infections, while teenagers more often had foot and nail infections. The study found that children living in rural areas had higher infection rates than those in cities, suggesting that environmental factors play an important role in fungal infection patterns.

Detection of Multiple Nosocomial Trichosporon asahii Transmission Events via Microsatellite Typing Assay, South America

mycolabadmin

Researchers developed a genetic fingerprinting tool called microsatellite typing to track and identify outbreaks of a dangerous fungus called Trichosporon asahii in hospitals. This fungus causes life-threatening infections, especially in sick patients with weakened immune systems, and is resistant to many antifungal medications. By analyzing samples from hospitals across South America, scientists discovered multiple instances where the same strain of this fungus infected patients in different hospitals over many years. This new testing method is much cheaper and faster than other genetic tests, making it practical for hospitals worldwide to monitor and control infections caused by this emerging pathogen.

Detection of Mucorales antigen in bronchoalveolar lavage samples using a newly developed lateral-flow device

mycolabadmin

Researchers tested a new rapid test device that detects a specific protein released by dangerous mold infections (mucormycosis) in patient respiratory samples. The test uses a special antibody to identify these molds quickly, which is important because mucormycosis can be life-threatening and requires fast treatment. The device showed promise with about 77% accuracy in identifying infections, though larger studies are needed to confirm these findings.

The first described case of Fomitiporella micropora infection in humans: A heart transplant recipient diagnosed by fungal PCR

mycolabadmin

A patient who received a heart transplant developed a small, slowly-growing lump on his shin over many years. After surgical removal, genetic testing revealed it was caused by a rare fungus never before identified in humans. The surgical removal likely cured the infection, and the case shows how important advanced genetic testing methods are for identifying unusual infections in transplant patients.

A case of refractory onychomycosis caused by Kloeckera apiculata: Successful treatment with itraconazole

mycolabadmin

A 32-year-old man had a stubborn fungal nail infection caused by an extremely rare yeast called Kloeckera apiculata that didn’t respond to three different antifungal treatments over several years. After being identified through specialized laboratory testing including genetic sequencing, the infection was successfully cured with a 3-month course of the oral antifungal medication itraconazole. This case is notable because it is only the fourth known case of this rare fungal infection in humans and the first one to achieve complete cure with itraconazole treatment.

Corrigendum: Navigating the fungal battlefield: cysteine-rich antifungal proteins and peptides from Eurotiales

mycolabadmin

This article provides a correction to previously published research about special proteins and peptides produced by certain fungi that can fight other fungal infections. The corrections involve fixing errors in a table that listed important chemical properties of these antifungal molecules. These molecules come from various Penicillium and Aspergillus fungal species and could potentially be used to develop new antifungal treatments.

Reevaluating the Value of (1,3)-β-D-Glucan for the Diagnosis of Intra-Abdominal Candidiasis in Critically Ill Patients: Current Evidence and Future Directions

mycolabadmin

This review examines how a fungal biomarker called beta-D-glucan (BDG) can help doctors diagnose yeast infections in the abdomens of critically ill patients. While BDG tests in the blood are available, they give many false positives. Testing BDG directly in fluid from the abdomen appears more accurate, especially when combined with blood tests. However, more research is needed before hospitals widely adopt this approach in daily practice.

Trichosporon species bloodstream infections in a tertiary care hospital in the western region of Saudi Arabia: A 7-year retrospective chart review from 2016 to 2022

mycolabadmin

This study examined a rare but dangerous fungal infection called Trichosporonosis that affects the bloodstream in hospitalized patients. Researchers found that this infection kills about 60% of patients despite treatment with antifungal medications. The infection is often caused by a fungus called Trichosporon asahii and typically occurs in patients with weakened immune systems who are already hospitalized and using catheters.

Emerging Infections Network Survey of Screening for Cryptococcal Antigenemia, United States, 2024

mycolabadmin

Researchers surveyed infectious disease doctors across the United States to understand how often they test HIV patients for cryptococcal antigen, a fungal infection that can be serious. The study found that doctors don’t consistently follow recommended screening guidelines, with many uncertain about the benefits of testing. Key barriers included confusion about testing recommendations and concerns about delaying HIV treatment, suggesting that doctors need better education about the importance of early detection.

Research Topic: Fungal infections